Ocular Therapeutix, Inc

OCUL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001393434

SEC filings (opens in a new tab)

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Ocular Therapeutix, Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of OCUL: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	168	3	180	+15
Shares	140.0M	249.9K	133.8M	−5.86M (−4.2%)
Value	$1.22B	$2.17M	$1.14B	−$74.6M (−6.1%)

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Ocular Therapeutix, Inc at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to OCUL in Q4 2024
Institution	Shares	Value	% of portfolio
Millennium Management LLC	447,237	$3.82M	0.00%
First Trust Advisors LP	212,944	$1.82M	0.00%
Raymond James Financial Inc	201,623	$1.72M	0.00%
RoundAngle Advisors LLC	198,456	$1.69M	1.61%
Saturn V Capital Management LLC	191,456	$1.64M	0.64%
Hussman Strategic Advisors, Inc.	105,000	$896.7K	0.26%
Balyasny Asset Management LLC	97,553	$833.1K	0.00%
Courier Capital LLC	56,438	$482.0K	0.03%
Truist Financial Corp	50,000	$427.0K	0.00%
Graham Capital Management, L.P.	37,577	$320.9K	0.01%
Police & Firemen's Retirement System of New Jersey	33,708	$287.9K	0.00%
D. E. Shaw & Co., Inc.	31,419	$268.3K	0.00%
Brevan Howard Capital Management LP	24,078	$205.6K	0.01%
Aigen Investment Management, LP	18,588	$158.7K	0.03%
KLP Kapitalforvaltning AS	17,400	$148.6K	0.00%
CIBC World Markets Corp	14,562	$124.4K	0.00%
Freestone Grove Partners LP	13,931	$119.0K	0.00%
Campbell & CO Investment Adviser LLC	12,071	$103.1K	0.01%
Palumbo Wealth Management LLC	11,693	$99.9K	0.04%
XTX Topco Ltd	11,593	$99.0K	0.01%
Walleye Capital LLC	10,548	$90.1K	0.00%
Quest Partners LLC	6,162	$52.6K	0.01%
Atlas Capital Advisors LLC	5,000	$42.7K	0.01%
GF Fund Management Co. Ltd.	3,301	$28.2K	0.00%
Skopos Labs, Inc.	2,083	$17.8K	0.01%
Aster Capital Management (DIFC) Ltd	1,431	$12.2K	0.00%
Clear Street Markets LLC	1,311	$11.2K	0.00%
State of Wyoming	1,049	$8.96K	0.00%
Canada Pension Plan Investment Board	800	$6.83K	0.00%
SBI Securities Co., Ltd.	36	$307	0.00%
IFP Advisors, Inc	0	$196	0.00%
Macquarie Group Ltd	10,548	$90	0.00%

Sold out (17)

Institutions that held Ocular Therapeutix, Inc at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of OCUL in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Assenagon Asset Management S.A.	2,825,756	$24.6M
Braidwell LP	2,239,770	$19.5M
PFM Health Sciences, LP	402,843	$3.50M
Gsa Capital Partners LLP	126,681	$1.10M
Jane Street Group, LLC	124,542	$1.08M
Marshall Wace, LLP	87,743	$763.4K
American Century Companies Inc	74,491	$648.1K
Verition Fund Management LLC	62,501	$543.8K
Caption Management, LLC	22,900	$199.2K
Sherbrooke Park Advisers LLC	22,649	$197.0K
Squarepoint Ops LLC	22,478	$195.6K
Mangrove Partners	21,416	$186.3K
Scotia Capital Inc.	12,138	$105.6K
Acadian Asset Management LLC	8,142	$70.0K
Capital Performance Advisors LLP	8,034	$69.9K
Catalyst Funds Management Pty Ltd	5,600	$48.7K
Golden State Equity Partners	3,250	$28.3K

Not filed for Q4 2024 yet (3)

Institutions that held Ocular Therapeutix, Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Raymond James & Associates	142,108	$1.24M
Raymond James Financial Services Advisors, Inc.	96,644	$840.8K
AJOVista, LLC	11,123	$96.8K